CD4 and congenital rubella syndrome: Vaccine-induced, relatively more abundant, SARS-CoV-2–specific CD4+ T cells can eliminate infected monocytes, immune cells implicated in CRS and systemic inflammatory syndrome, and halt disease progression and prevent severe infection.